130 related articles for article (PubMed ID: 31839073)
1. [Application of TMA Technology in Donors' HBV-DNA Detection].
Ren BC; Zhou XZ; Zhuo XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1998-2002. PubMed ID: 31839073
[TBL] [Abstract][Full Text] [Related]
2. Blood test strategy of blood donors, ALT and HBsAg HCV-Ab correlation study.
Zheng L; Li X
Minerva Med; 2019 Feb; 110(1):18-26. PubMed ID: 30458610
[TBL] [Abstract][Full Text] [Related]
3. Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing.
Lelie N; Bruhn R; Busch M; Vermeulen M; Tsoi WC; Kleinman S;
Transfusion; 2017 Jan; 57(1):24-35. PubMed ID: 27673757
[TBL] [Abstract][Full Text] [Related]
4. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
5. Molecular characteristics of HBV infection among blood donors tested HBsAg reactive in a single ELISA test in southern China.
Ye X; Li T; Li R; Liu H; Zhao J; Zeng J
BMC Infect Dis; 2021 Jan; 21(1):83. PubMed ID: 33468062
[TBL] [Abstract][Full Text] [Related]
6. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
Martin LA; Stramer SL; Kuhns MC; Schlauder GG
Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
[TBL] [Abstract][Full Text] [Related]
7. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of hepatitis B virus infections in blood donors in southern China that are surface antigen positive but nucleic acid testing negative.
Ye X; Li T; Zhang R; Liu H; Zeng J; Hong W; Lu L; Zhu W; Li S; Xu M; Wu S; Chen L
Transfusion; 2020 Jul; 60(7):1476-1482. PubMed ID: 32358842
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
González R; Torres P; Castro E; Barbolla L; Candotti D; Koppelman M; Zaaijer HL; Lelie N; Allain JP; Echevarría JM
Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
[TBL] [Abstract][Full Text] [Related]
10. [Study about seroconversion of HBV NAT screening-positive crowd from blood donors].
Wang DW; Wang TB; Liu FP; Shi LL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):127-9. PubMed ID: 18574536
[TBL] [Abstract][Full Text] [Related]
11. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
Shang G; Yan Y; Yang B; Shao C; Wang F; Li Q; Seed CR
Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
[TBL] [Abstract][Full Text] [Related]
12. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India.
Keechilot CS; Shenoy V; Kumar A; Biswas L; Vijayrajratnam S; Dinesh K; Nair P
Pathog Glob Health; 2016; 110(7-8):287-291. PubMed ID: 27788631
[TBL] [Abstract][Full Text] [Related]
13. [Blood Test Patterns for Blood Donors after Nucleic Acid Detection in the Blood Center].
Men SS; Lv LZ; Chen YF; Han CH; Liu HY; Yan Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1815-1819. PubMed ID: 29262922
[TBL] [Abstract][Full Text] [Related]
14. Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination.
Altunay H; Kosan E; Birinci I; Aksoy A; Kirali K; Saribas S; Aslan M; Yuksel P; Alan E; Yenen OS; Kocazeybek B
Transfus Apher Sci; 2010 Dec; 43(3):265-268. PubMed ID: 20934912
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
Kleinman SH; Strong DM; Tegtmeier GG; Holland PV; Gorlin JB; Cousins C; Chiacchierini RP; Pietrelli LA
Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
[TBL] [Abstract][Full Text] [Related]
17. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
18. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
Alizadeh Z; Milani S; Sharifi Z
Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
[TBL] [Abstract][Full Text] [Related]
19. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing.
Weber B; Mühlbacher A; Melchior W
J Clin Virol; 2005 Jan; 32(1):67-70. PubMed ID: 15572009
[TBL] [Abstract][Full Text] [Related]
20. NAT for HBV and anti-HBc testing increase blood safety.
Roth WK; Weber M; Petersen D; Drosten C; Buhr S; Sireis W; Weichert W; Hedges D; Seifried E
Transfusion; 2002 Jul; 42(7):869-75. PubMed ID: 12375659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
